and that's especially true in an environment like this one. where so many hedge funds are lagging the market and so few really hot growth stocks. these guys are fighting for their professional lives, people. so they know they can't afford to have their clients ask them, you moron, why didn't you own google or visa or amazon or vista ulta salon or tractor supply, sherwin-williams or diageo. i believe they have been anointed by growth orient eed portfolio managers. if it's a really bad market it won't matter, but i had stay focused on the hot list between now and the last week of december. and that brings me to two new ones. the last anointed names that round out the series. two smoking biotech stocks that have been rallying like crazy. first one is alexon a alexion, r the year and gilead, up 66% over the same period. alexion is one of these orphan drug companies, solarus treats rare blood disorders, called pnh it can lead to an emma, clotting and death. they g when you have a drug that treats an ultra rare, often lethal condition with no known